Taiho Pharmaceutical Co., Ltd. is engaged in the research, development, production, distribution, and marketing of pharmaceutical products. The company develops drugs primarily in the area of oncology. It also develops other pharmaceuticals, controlled medical devices, designated quasi-drugs, second-class OTC drugs, designated second-class OTC drugs, and third-class OTC drugs; S-1 for the treatment of gastric cancer; TAS-102 for the treatment of colorectal cancer; and anticancer agents for oncologists, other medical care professionals, and patients. In addition, it engages in the research and development in the areas of oncology,

Lunan Pharmaceutical Group is an Integrated pharmaceutical group, National innovative enterprise and National torch plan key high-tech enterprise that produces, researches and sells both traditional Chinese medicine, chemical medicine and bio-pharmaceutical medicinal products.

Part of Lunan Pharmaceutical Group Co., Ltd., Shandong New Time Pharmaceutical Co. Ltd. is a Chinese company located in Linyi that manufactures pharmaceutical products.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of drugs. It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs. The firm’s products include tablets, oral solution, and suspension of antineoplastic drugs and narcotic drugs; psychotropic substances; soft capsules; freeze-dried powder injection; powder injection; high-volume injection, including multi-layer co-extruded infusion bag, with anti-tumor drugs; small volume injections, including antineoplastic drugs, psychotropic drugs, and non-final sterilization; biological engineering products such as polyethylene glycol recombinant human granulocyte stimulating factor injection; hard capsules; granules; powder; and film and gel. The company was founded in 1970 and is headquartered in Lianyungang, China.

Part of Kitasato University, The Kitasato Institute is a company headquartered in Tokyo, Japan, that operates a research institution.

Lunan New Times Biotechnology Co., Ltd., established on 2007-03-15, Business scope includes biotechnology products,Pharmaceutical Intermediates,Raw materials and preparations,Healthy food,food,Research and Development of Cosmetics,production and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Tianjin Jinyao Group Co. Ltd. is a Chinese private company located in Tianjin. The firm manufactures pharmaceutical products.

Shenzhen Wanle Pharmaceutical Co., Ltd., established on 1990-07-04, Business scope includes general business items:,The licensing program is:to develop,Research,Production and operation of raw materials,small volume injection(Contains anti-tumor),Freeze-dried powder injection(Contains anti-tumor),tablet,Capsules(contain anti-tumor),Imported medicines are packaged separately(tablet),Accessories(Polyethylene glycol monomethyl ether-polylactic acid block copolymer),Goods and technology import and export business.

Qilu Pharmaceutical (Hainan) Co., Ltd., established on 2005-10-18, The business scope includes chemical raw materials and their preparations;Antibiotic raw materials and their preparations;biochemical drug;Biological product.

Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., established on 2001-08-31, Business scope includes pharmaceuticals,Research and Development of Disinfectants,production and sales(Operate according to the scope listed in the license,involved in the law,Do not operate if prohibited by laws and regulations,Operating with a license involved in operating with a license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. Qilu focuses on the development, manufacturing and marketing of generic drugs and active pharmaceutical ingredients(APIs) in therapeutic areas including but not limited to Oncology, Cerebrovascular & Cardiovascular, Anti-infections, Psychological & Neurological Systems, Respiratory System, and Ophthalmological Diseases. Qilu has more than 15,000 employees, 70% of whom have a college degree or above. Qilu Pharmaceutical consistently focuses on revolutionary development strategies guided by market demand and product innovation. Qilu has established extensive cooperation with domestic and international partners on multiple R&D projects. Devoted to the cultivation of talent, Qilu has invested in a highly qualified R&D team and efficient R&D capabilities. The 200+ new drug products successfully developed by Qilu constitutes as a large part of future production and sales for Qilu Pharmaceutical and partners. A number of technological achievements have garnered national and provincial scientific and technological progress awards for Qilu.

Jiangsu Yangtze River Pharmaceutical Group Co., Ltd. manufactures and distributes pharmaceutical products. It is a large cross-regional pharmaceutical group that features industry-university-institute cooperation and integrates scientific research, industrial production and sale. The company was founded in 1971 and is headquartered in Taizhou, China.

Beijing Weiyi Sunshine Commodity Sales Co., Ltd., established on 2013-01-24, Business scope includes sales of prepackaged food(Does not contain refrigerated frozen food);special food sales(Healthy food);Sales of daily necessities,cosmetic,household appliances,kitchen utensils;technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Health Advisory,health management(Except for medical treatment activities subject to approval).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Toyota is a company that is operating its business with a focus on vehicle production and sales. Toyota completed its A1 prototype passenger car and the G1 truck in 1935. The first export of a Toyota car (G1 truck) occurred in 1936 and Toyota established its logo during the same year. By 1938, it started the production of the G1 truck. In 1957, Toyota exported the Japanese passenger car ‘Crown’ to the United States for the first time. Toyota Motor Sales, U.S.A. was also established in 1957. In 1985, Toyota’s cumulative exports reached 20 million units, and its annual overseas output exceeded 3 million units in 1999. As of the end of Dec. 2013, Toyota conducts its business worldwide with 52 overseas manufacturing companies in 27 countries and regions. Toyota's vehicles are sold in more than 160 countries and regions. Toyota today manufactures a diverse line-up of vehicles all over the world, including sport utility vehicles, commercial vehicles, and more. Toyota was founded in 1937 by Kiichiro Toyoda and is headquartered in Aichi.

Shenzhen Neptunus Medical Technology Research Institute Co., Ltd., established on 2016-06-07, Business scope includes general business items:biomedical products,Health Care Products,food,Research and Development of Cosmetics,technology transfer,Technical Services,technical consulting;Domestic Trade,Operating import and export business,Invest in business(Specific projects will be reported separately).(law,Administrative regulations,The State Council decides to prohibit and require approval before registration except for items),The licensing program is:Pharmaceutical commissioned production and commissioned sales;Health Care Products,food,Consignment production and sales of cosmetics.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wuhan Jiesheng Biotechnology Co., Ltd., established on 2013-01-30, Business scope includes biotechnology products,Health Care Products,Technical research on chemical products,technology development,technology transfer,Technical Services;Fine Chemicals(Does not contain dangerous goods)promotion of;Import and export,Technology Import and Export,Agent import and export(Goods and technologies prohibited by the state from import and export are not included).(In the scope of the above, the state-owned special regulations need to be examined and approved. The project can only be operated after approval or with a valid license.)

Anfa (Fujian) Biotechnology Co., Ltd., established on 2005-07-06, Business scope includes health food,substitute tea,Confectionery(candy),Tea and related products,beverage development,Production;medicinal mushroom,Development and cultivation of fruit and vegetable plants;Seafood Development;Production of health care equipment(Not involved in the production of medical devices);Wholesale and Retail Health Food(Anfa Gannuobaoli Capsules),food,dairy products(Contains infant formula milk powder),cosmetic;technology R & D,Communication and promotion;Import and export of goods and technology.(The above commodities involve quotas,license-managed,Apply in accordance with relevant national regulations).Within the geographical scope approved by the examination and approval department(The specific area is subject to the announcement of the Ministry of Commerce's direct selling industry management website)Sell ​​related products produced by the company and the holding company through direct sales(The specific products are subject to the announcement on the website of the Ministry of Commerce's direct selling industry management information system).Cultural exhibition service;Other daily necessities retail;liquor,Beverage and tea retail(Does not include border ports);Production and sales of non-medical daily protective masks;Sales of Class III Medical Devices;Other unspecified biotechnology extension services;internet retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)